Micro Imaging Technology Inc (MMTC)

[1stock]

BIOTEK & MMTC

MIT has demonstrated the ability to detect and identify, within several minutes, the microbes Escherichia coli, Listeria, Salmonella, Staphylococcus aureus, and other pathogenic bacteria. The Company recently performed more than 300 tests for the identification of the previously named contaminants and scored 95 percent accuracy.

North American Science Associates, Inc. (NAMSA) has also verified the identification process. NAMSA is an independent and internationally recognized bioscience-testing laboratory. The NAMSA Test Report demonstrates the accuracy, speed, and cost effectiveness of the MIT 1000 System over conventional processes.

On October 21, 2009, Biotek Sdn Bhd (Biotek) purchased their first MIT 1000 System to establish a demonstration laboratory. Biotek was appointed as MIT’s Distributor for Malaysia and other Association of Southeast Asian Nations (ASEAN). These include Indonesia, Singapore, The Philippines, Thailand, and Cambodia.

Several Biotek executives, including Director Weng Cheong Fong, visited MIT’s laboratories earlier this week for additional training. During the session, the Biotek executives committed to accepting five MIT 1000 Systems by late summer and ten additional units early in 2012.